Infants who are exposed early to certain bacteria may have a lower risk of developing allergies. A recent study published in Nature Microbiology highlights this connection. Researchers found that specific strains of bifidobacteria in the gut can influence immune responses.
The study tracked 147 children from birth to age five. It showed that infants with high levels of these good bacteria in their gut were less likely to develop allergies and eczema as they grew. The researchers focused on bifidobacteria that produce aromatic lactates, which appear to play a role in immune regulation.
A key finding was the link between these bacteria and lower levels of specific immunoglobulin E (IgE), an antibody associated with allergic reactions. Infants with more of these beneficial gut bacteria had up to 14 times higher chances of acquiring them if they were born vaginally and breastfed exclusively for the first two months.
Professor Susanne Brix Pedersen of the Technical University of Denmark noted that while the bacteria seem to reduce IgE production, the precise mechanisms are still not fully understood. “We know humans have unique receptors that might interact with these metabolites, but the details are still unclear,” she explained.
This research presents exciting possibilities for preventing allergies, potentially leading to new probiotics or formula designs. However, Pedersen emphasized that more studies are needed to establish a causal relationship.
This approach reflects a broader trend in health research focusing on the gut microbiome’s role in human health. For example, a 2022 study found that a diverse gut microbiota might reduce the risk of autoimmune conditions later in life.
As we continue to learn about the gut’s influence on our immune system, the future might hold more strategies to combat childhood allergies effectively.
For more on this topic, you can check out the full study here.
